MA24794A1 - D-methadone, un analgesique nonopioique - Google Patents

D-methadone, un analgesique nonopioique

Info

Publication number
MA24794A1
MA24794A1 MA24934A MA24934A MA24794A1 MA 24794 A1 MA24794 A1 MA 24794A1 MA 24934 A MA24934 A MA 24934A MA 24934 A MA24934 A MA 24934A MA 24794 A1 MA24794 A1 MA 24794A1
Authority
MA
Morocco
Prior art keywords
alpha
subject
methadone
nonopioic
analgesic
Prior art date
Application number
MA24934A
Other languages
English (en)
Original Assignee
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Res Foundation Inc filed Critical Cornell Res Foundation Inc
Publication of MA24794A1 publication Critical patent/MA24794A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA24934A 1997-01-22 1998-01-22 D-methadone, un analgesique nonopioique MA24794A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3530897P 1997-01-22 1997-01-22

Publications (1)

Publication Number Publication Date
MA24794A1 true MA24794A1 (fr) 1999-12-31

Family

ID=21881853

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24934A MA24794A1 (fr) 1997-01-22 1998-01-22 D-methadone, un analgesique nonopioique

Country Status (12)

Country Link
US (1) US6008258A (fr)
EP (1) EP1003494B1 (fr)
JP (2) JP4514241B2 (fr)
AT (1) ATE357226T1 (fr)
AU (1) AU6244898A (fr)
CA (1) CA2278422C (fr)
DE (1) DE69837387T2 (fr)
DK (1) DK1003494T3 (fr)
ES (1) ES2283049T3 (fr)
MA (1) MA24794A1 (fr)
PT (1) PT1003494E (fr)
WO (1) WO1998031358A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999045906A1 (fr) * 1998-03-09 1999-09-16 Trustees Of Tufts College Traitement des comportements compulsifs chez l'homme et l'animal
US20070197651A1 (en) * 1998-03-09 2007-08-23 Tufts University Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors
US20060167114A1 (en) * 1998-03-09 2006-07-27 Louis Shuster Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors
KR100762018B1 (ko) * 1998-07-16 2007-10-04 메모리얼 슬로안-케터링 캔서 센터 오피오이드 진통제 및 엔엠디에이 길항제를 함유하는 국소조성물
US6897242B1 (en) * 1999-02-24 2005-05-24 Judson J. Somerville Non-racemic mixtures of d- and l- methadone and method of treating pain
AU2001251374A1 (en) * 2000-04-07 2001-10-23 Ultramed International, Inc. Maintaining abstinence after detoxification from opiate addiction
CA2407683C (fr) 2000-04-28 2010-04-13 Memorial Sloan-Kettering Cancer Center Formulations topiques a base d'anesthesique et d'opioide, et utilisations associees
US7820688B2 (en) 2001-04-27 2010-10-26 Memorial Sloan-Kettering Cancer Center Topical anesthetic/opioid formulations and uses thereof
JP2005518411A (ja) * 2002-01-16 2005-06-23 エンド ファーマシューティカルズ インコーポレーテッド 中枢神経系の障害を治療する製薬組成物及び方法
CA2476565A1 (fr) * 2002-01-23 2003-07-31 The Regents Of The University Of California Procedes et compositions destines a reduire le developpement de tolerance au medicament et/ou de dependance physique
EP1531792A4 (fr) * 2002-05-13 2006-10-04 Endo Pharmaceuticals Inc Forme posologique opioide empechant une utilisation abusive
JP2006500395A (ja) * 2002-09-09 2006-01-05 エンド ファーマシューティカルズ インコーポレーテッド 組み合わされた即時放出及び徐放の鎮痛組成物
US20040180915A1 (en) * 2003-03-14 2004-09-16 Xanodyne Pharmacal, Inc. Methadone-containing compositions for parenteral administration and method of use thereof
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
US20100010096A1 (en) * 2006-10-27 2010-01-14 John Charin Somberg Methadone chiral isolate as an improved pharmaceutical
US20100048605A1 (en) * 2006-12-11 2010-02-25 University Of Kentucky Research Foundation Synergistic effects of combinations of nornicotine and opioids for the treatment of pain
US9468611B2 (en) * 2012-09-27 2016-10-18 Relmada Therapeutics, Inc. d-Methadone for the treatment of psychiatric symptoms
KR20240148948A (ko) * 2017-01-31 2024-10-11 파올로 엘. 만프레디 신경계 장애의 치료에서 사용하기 위한 ｄ-메타돈 및 이의 유도체
WO2018183320A1 (fr) * 2017-03-31 2018-10-04 Depco, Inc. Mastic thérapeutique à analgésiques et/ou révulsifs
MX2021009187A (es) * 2019-01-30 2021-11-12 Univ Of Padova Opioides estructuralmente modificados para la prevención y tratamiento de enfermedades y afecciones.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3895056A (en) * 1972-12-26 1975-07-15 Lilly Co Eli Alpha-d1-4-acetoxy-1-methyl-3,3-diphenylhexylamine and salts
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
US5352683A (en) * 1993-03-05 1994-10-04 Virginia Commonwealth University Medical College Of Virginia Method for the treatment of chronic pain
CA2115792C (fr) * 1993-03-05 2005-11-01 David J. Mayer Methode de traitement de la douleur

Also Published As

Publication number Publication date
AU6244898A (en) 1998-08-07
PT1003494E (pt) 2007-06-06
JP4514241B2 (ja) 2010-07-28
DE69837387D1 (de) 2007-05-03
DK1003494T3 (da) 2007-07-16
WO1998031358A1 (fr) 1998-07-23
US6008258A (en) 1999-12-28
CA2278422A1 (fr) 1998-07-23
EP1003494A1 (fr) 2000-05-31
JP2001508797A (ja) 2001-07-03
EP1003494A4 (fr) 2002-10-16
CA2278422C (fr) 2007-11-13
EP1003494B1 (fr) 2007-03-21
JP2010013477A (ja) 2010-01-21
ES2283049T3 (es) 2007-10-16
DE69837387T2 (de) 2007-12-13
ATE357226T1 (de) 2007-04-15

Similar Documents

Publication Publication Date Title
MA24794A1 (fr) D-methadone, un analgesique nonopioique
NZ331189A (en) Method of detection of influenza virus using neuraminidase binders
IL128003A (en) MULTISPECIFIC BINDING MOLECULES COMPRISING A BINDING DETERMINANT WHICH BINDS AN FCalpha RECEPTOR
FR12C0001I2 (fr) Anticorps se liant de maniere immunospecifique a un stimulateur de lymphocyte b
ATE301994T1 (de) Verfahren zur erleichterung von schmerzen durch eine kombination von tramadol und einen nmda- antagonist
FI965203A7 (fi) Morfiinia, polypyrrolidonia ja polyalkyleenioksidia sisältävä koostumus
CA2146973A1 (fr) Utilisations d'un fragment du recepteur du tgf-.beta. a des fins therapeutiques
DE69733081D1 (de) Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
BR9910180A (pt) Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
AU1718400A (en) Method for treating pain
DK0942740T3 (da) Kombinationsterapi under anvendelse af et TFN-bindende protein til behandling af TFN-medierede sygdomme
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
DK1063995T3 (da) Kombination til behandling af alkoholafhængighed indeholdende en opiod-antagonist og en NMDA-receptorkompleks-modulator
BR0110208A (pt) Composições e terapias para distúrbios associados com hiperlipidemia
SE9603725D0 (sv) New teatment
ATE221391T1 (de) Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln
DK0946157T3 (da) Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte
DK0846173T3 (da) Anvendelse af et anti-interleukin-9-antistof til fremstilling af et lægemiddel til behandling af astma
EA199800866A1 (ru) Способ снятия боли
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
WO1998020835A3 (fr) Methode pour traiter l'hyperlipidemie chez l'homme
CA2299400A1 (fr) Methode de traitement de dyskinesies liees a une maladie ou provoquees par l'absorption de medicaments
EA199800535A1 (ru) Способ лечения боли
WO2000051632A3 (fr) Agoniste du cuivre qui se lie au site de fixation de cuivre de l'app et/ou exerce une action d'inhibition sur la liberation du peptide beta-amyloide
AU4937499A (en) Use of succinic acid or salts thereof and method of treating insulin resistance